guest ::
| Home > Publications database > Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation. > print |
| Home > Publications database > Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation. > print |
| 001 | 119323 | ||
| 005 | 20240228145432.0 | ||
| 024 | 7 | _ | |a 10.1002/ijc.30561 |2 doi |
| 024 | 7 | _ | |a pmid:27935045 |2 pmid |
| 024 | 7 | _ | |a 0020-7136 |2 ISSN |
| 024 | 7 | _ | |a 1097-0215 |2 ISSN |
| 037 | _ | _ | |a DKFZ-2017-00078 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Dieter, Sebastian |0 P:(DE-He78)34c336827b750ba10a020fd62ec4664f |b 0 |e First author |
| 245 | _ | _ | |a Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation. |
| 260 | _ | _ | |a Bognor Regis |c 2017 |b Wiley-Liss |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1533820650_21255 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Patient-derived cancer xenografts (PDX) are widely used to identify and evaluate novel therapeutic targets, and to test therapeutic approaches in preclinical mouse avatar trials. Despite their widespread use, potential caveats of PDX models remain considerably underappreciated. Here, we demonstrate that EBV-associated B-lymphoproliferations frequently develop following xenotransplantation of human colorectal and pancreatic carcinomas in highly immunodeficient NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl) /SzJ (NSG) mice (18/47 and 4/37 mice, respectively), and in derived cell cultures in vitro. Strikingly, even PDX with carcinoma histology can host scarce EBV-infected B-lymphocytes that can fully overgrow carcinoma cells during serial passaging in vitro and in vivo. As serial xenografting is crucial to expand primary tumor tissue for biobanks and cohorts for preclinical mouse avatar trials, the emerging dominance of B-lymphoproliferations in serial PDX represents a serious confounding factor in these models. Consequently, repeated phenotypic assessments of serial PDX are mandatory at each expansion step to verify 'bona fide' carcinoma xenografts. |
| 536 | _ | _ | |a 317 - Translational cancer research (POF3-317) |0 G:(DE-HGF)POF3-317 |c POF3-317 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Giessler, Klara |0 P:(DE-He78)30359063e6dfdc26aeb476fcd7cf696f |b 1 |e First author |
| 700 | 1 | _ | |a Kriegsmann, Mark |b 2 |
| 700 | 1 | _ | |a Dubash, Taronish Dorab |0 P:(DE-He78)fd92a33f8a02f962db52bf8daa1b1dbf |b 3 |
| 700 | 1 | _ | |a Möhrmann, Lino |0 P:(DE-He78)79e92bc6260b7a24abe4daf4378bf19c |b 4 |
| 700 | 1 | _ | |a Schulz, Erik |0 P:(DE-He78)2c03ff333ee046513a6a0ccb2ad67832 |b 5 |
| 700 | 1 | _ | |a Siegl, Christine |0 P:(DE-He78)be98d27bcd782f4e5961b646107dc14b |b 6 |
| 700 | 1 | _ | |a Weber, Sarah |0 P:(DE-He78)4f46d49c3232f5f84d315c1fcb36943e |b 7 |
| 700 | 1 | _ | |a Strakerjahn, Hendrik |0 P:(DE-He78)0922b09fe35a55ae6cf8cd5f01870a58 |b 8 |
| 700 | 1 | _ | |a Oberlack, Ava |0 P:(DE-He78)a8119728f4aa0683aeaea2022f9dd9f4 |b 9 |
| 700 | 1 | _ | |a Heger, Ulrike |b 10 |
| 700 | 1 | _ | |a Gao, Jianpeng |0 P:(DE-He78)a18dee684cb5c29dfc8762353b1db8cf |b 11 |
| 700 | 1 | _ | |a Hartinger, Eva-Maria |0 P:(DE-He78)76979443ff4a453358bf633af113184a |b 12 |
| 700 | 1 | _ | |a Oppel, Felix |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Hoffmann, Christopher M |b 14 |
| 700 | 1 | _ | |a Ha, Nati |0 P:(DE-He78)83832391027a1f2f4d46ef882ff3a47d |b 15 |
| 700 | 1 | _ | |a Brors, Benedikt |0 P:(DE-He78)fc949170377b58098e46141d95c72661 |b 16 |
| 700 | 1 | _ | |a Lasitschka, Felix |b 17 |
| 700 | 1 | _ | |a Ulrich, Alexis |b 18 |
| 700 | 1 | _ | |a Strobel, Oliver |b 19 |
| 700 | 1 | _ | |a Schmidt, Manfred |0 P:(DE-He78)b91bec47a4148ba68a58ab292d5860f2 |b 20 |
| 700 | 1 | _ | |a von Kalle, Christof |0 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de |b 21 |
| 700 | 1 | _ | |a Schneider, Martin |b 22 |
| 700 | 1 | _ | |a Weichert, Wilko |0 P:(DE-HGF)0 |b 23 |
| 700 | 1 | _ | |a Ehrenberg, K Roland |0 P:(DE-HGF)0 |b 24 |
| 700 | 1 | _ | |a Glimm, Hanno |0 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9 |b 25 |e Last author |
| 700 | 1 | _ | |a Ball, Claudia |0 P:(DE-He78)7a10ea1b9b2872da9f375002c44ddfce |b 26 |e Last author |
| 773 | _ | _ | |a 10.1002/ijc.30561 |g Vol. 140, no. 6, p. 1356 - 1363 |0 PERI:(DE-600)1474822-8 |n 6 |p 1356 - 1363 |t International journal of cancer |v 140 |y 2017 |x 0020-7136 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:119323 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)34c336827b750ba10a020fd62ec4664f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)30359063e6dfdc26aeb476fcd7cf696f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)fd92a33f8a02f962db52bf8daa1b1dbf |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)79e92bc6260b7a24abe4daf4378bf19c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)2c03ff333ee046513a6a0ccb2ad67832 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)be98d27bcd782f4e5961b646107dc14b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)4f46d49c3232f5f84d315c1fcb36943e |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)0922b09fe35a55ae6cf8cd5f01870a58 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)a8119728f4aa0683aeaea2022f9dd9f4 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)a18dee684cb5c29dfc8762353b1db8cf |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)76979443ff4a453358bf633af113184a |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)83832391027a1f2f4d46ef882ff3a47d |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)fc949170377b58098e46141d95c72661 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-He78)b91bec47a4148ba68a58ab292d5860f2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 24 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 25 |6 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 26 |6 P:(DE-He78)7a10ea1b9b2872da9f375002c44ddfce |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-317 |2 G:(DE-HGF)POF3-300 |v Translational cancer research |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2017 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b INT J CANCER : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b INT J CANCER : 2015 |
| 920 | 1 | _ | |0 I:(DE-He78)G010-20160331 |k G010 |l Geschäftsstelle |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)G100-20160331 |k G100 |l Translationale Onkologie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)G200-20160331 |k G200 |l Angewandte Bioinformatik |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)M110-20160331 |k M110 |l Epidemiologisches Krebsregister Baden-Württemberg |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 4 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)G010-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G100-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G200-20160331 |
| 980 | _ | _ | |a I:(DE-He78)M110-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|